アンチエイジングの世界市場の評価：製品カテゴリ別、タイプ別、成分別、人口統計別、投与経路別、流通チャネル別、地域別、機会、予測（2017年～2031年）

世界のアンチエイジングの市場規模は、2023年の800億3,000万米ドルから2031年に1,389億5,000万米ドルに達すると予測され、2024年～2031年の予測期間にCAGRで7.14%の成長が見込まれます。市場は、美の基準に対する意識の高まりと人々の高い可処分所得に加え、体内の老化兆候を変化させることを可能にする医学の進歩により、高いペースで栄えています。

アンチエイジング製品は、シワ、肌の変色といった目に見える老化現象に対抗するために販売されている化粧品や治療製品です。製品には、レチノール、ヒアルロン酸、抗酸化剤などの有効成分を特徴とする美容液、クリーム、マスク、サプリメントなどがあります。アンチエイジング製品の需要が高いのには複数の理由があります。世界中の高齢化する人々は、若々しさを保つ方法を模索し、美容に対する意識が高まっています。この影響は、ソーシャルメディアが人々の肌に対する美容法への関心を強めているために高まっており、アンチエイジング製品に対する消費者の支出を上回っています。革新的な成分と新技術の開発は、各ブランドが効果を証明する新製品を発売し続けているため、この動向に拍車をかけています。加えて、ウェルネスやセルフケアを実践する消費者の動向の高まりは、スキンケアを健康に取り入れることを可能にし、アンチエイジング部門の急速な市場成長に寄与しています。例えば2024年8月、Purple Pompa Beauty Culture Private Limitedは、アンチエイジングとスキンリジュビネーションに焦点を当てた新しいスキンケア製品群を発売しました。この革新的な製品には、若々しい肌を促進し、全体的な顔色を向上させる先進の成分が配合されています。この発売は、品質と効能を保証しながら、さまざまな肌の悩みをターゲットに、現代のニーズに合わせた効果的なスキンケアソリューションを提供するというブランドのコミットメントを反映したものです。この製品群は、多様なタイプの肌に対応するようデザインされており、幅広い消費者層にアピールしています。

当レポートでは、世界のアンチエイジング市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のアンチエイジング市場の見通し（2017年～2031年）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • 製品カテゴリ別
  • タイプ別
  • 成分別
  • 人口統計別
  • 投与経路別
  • 流通チャネル別
  • 地域別
  • 市場シェア分析：企業別（金額）（上位5社とその他 - 2023年）
• 市場マップ分析（2023年）
  • 製品カテゴリ別
  • タイプ別
  • 成分別
  • 人口統計別
  • 投与経路別
  • 流通チャネル別
  • 地域別

第5章 北米のアンチエイジング市場の見通し（2017年～2031年）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • 製品カテゴリ別
  • タイプ別
  • 成分別
  • 人口統計別
  • 投与経路別
  • 流通チャネル別
  • シェア：国別
• 各国の市場の評価
  • 米国のアンチエイジング市場の見通し（2017年～2031年）
  • カナダ
  • メキシコ

第6章 欧州のアンチエイジング市場の見通し（2017年～2031年）

• ドイツ
• フランス
• イタリア
• 英国
• ロシア
• オランダ
• スペイン
• ポーランド

第7章 アジア太平洋のアンチエイジング市場の見通し（2017年～2031年）

• インド
• 中国
• 日本
• オーストラリア
• ベトナム
• 韓国
• インドネシア
• フィリピン

第8章 南米のアンチエイジング市場の見通し（2017年～2031年）

• ブラジル
• アルゼンチン

第9章 中東・アフリカのアンチエイジング市場の見通し（2017年～2031年）

• サウジアラビア
• アラブ首長国連邦
• 南アフリカ
• イスラエル

第10章 需給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

• 市場促進要因
• 市場の課題

第16章 市場の動向と発展

第17章 規制枠組みとイノベーション

• 臨床試験
• 規制当局の承認

第18章 特許情勢

第19章 ケーススタディ

第20章 競合情勢

• マーケットリーダー上位5社の競合マトリクス
• 上位5社のSWOT分析
• 主要企業上位10社の情勢
  • Allergan Inc.
  • Beiersdorf AG
  • Procter & Gamble Co.
  • Unilever plc
  • Cynosure Inc.
  • Shiseido Company Limited
  • Age Sciences Inc.
  • Lumenis Ltd.
  • Solta Medical Inc.
  • Nestle S.A.

第21章 戦略的推奨

第22章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 3. Global Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 4. Global Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 5. Global Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 6. Global Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 7. Global Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 8. Global Anti-Aging Market Share (%), By Region, 2017-2031F
• Figure 9. North America Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 10. North America Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 11. North America Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 12. North America Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 13. North America Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 14. North America Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 15. North America Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 16. North America Anti-Aging Market Share (%), By Country, 2017-2031F
• Figure 17. United States Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 18. United States Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 19. United States Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 20. United States Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 21. United States Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 22. United States Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 23. United States Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 24. Canada Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 25. Canada Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 26. Canada Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 27. Canada Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 28. Canada Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 29. Canada Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 30. Canada Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 31. Mexico Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 32. Mexico Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 33. Mexico Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 34. Mexico Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 35. Mexico Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 36. Mexico Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 37. Mexico Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 38. Europe Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 39. Europe Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 40. Europe Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 41. Europe Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 42. Europe Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 43. Europe Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 44. Europe Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 45. Europe Anti-Aging Market Share (%), By Country, 2017-2031F
• Figure 46. Germany Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 47. Germany Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 48. Germany Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 49. Germany Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 50. Germany Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 51. Germany Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 52. Germany Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 53. France Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 54. France Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 55. France Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 56. France Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 57. France Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 58. France Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 59. France Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 60. Italy Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 61. Italy Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 62. Italy Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 63. Italy Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 64. Italy Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 65. Italy Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 66. Italy Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 67. United Kingdom Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 68. United Kingdom Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 69. United Kingdom Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 70. United Kingdom Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 71. United Kingdom Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 72. United Kingdom Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 73. United Kingdom Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 74. Russia Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 75. Russia Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 76. Russia Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 77. Russia Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 78. Russia Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 79. Russia Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 80.
• Figure 81. Russia Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 82. Netherlands Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 83. Netherlands Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 84. Netherlands Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 85. Netherlands Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 86. Netherlands Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 87. Netherlands Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 88. Netherlands Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 89. Spain Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 90. Spain Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 91. Spain Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 92. Spain Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 93. Spain Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 94. Spain Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 95. Spain Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 96. Turkey Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 97. Turkey Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 98. Turkey Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 99. Turkey Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 100. Turkey Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 101. Turkey Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 102. Turkey Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 103. Poland Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 104. Poland Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 105. Poland Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 106. Poland Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 107. Poland Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 108. Poland Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 109. Poland Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 110. South America Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 111. South America Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 112. South America Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 113. South America Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 114. South America Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 115. South America Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 116. South America Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 117. South America Anti-Aging Market Share (%), By Country, 2017-2031F
• Figure 118. Brazil Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 119. Brazil Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 120. Brazil Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 121. Brazil Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 122. Brazil Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 123. Brazil Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 124. Brazil Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 125. Argentina Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 126. Argentina Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 127. Argentina Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 128. Argentina Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 129. Argentina Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 130. Argentina Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 131. Argentina Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 132. Asia-Pacific Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 133. Asia-Pacific Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 134. Asia-Pacific Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 135. Asia-Pacific Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 136. Asia-Pacific Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 137. Asia-Pacific Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 138. Asia-Pacific Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 139. Asia-Pacific Anti-Aging Market Share (%), By Country, 2017-2031F
• Figure 140. India Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 141. India Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 142. India Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 143. India Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 144. India Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 145. India Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 146. India Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 147. China Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 148. China Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 149. China Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 150. China Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 151. China Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 152. China Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 153. China Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 154. Japan Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 155. Japan Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 156. Japan Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 157. Japan Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 158. Japan Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 159. Japan Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 160. Japan Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 161. Australia Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 162. Australia Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 163. Australia Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 164. Australia Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 165. Australia Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 166. Australia Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 167. Australia Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 168. Vietnam Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 169. Vietnam Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 170. Vietnam Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 171. Vietnam Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 172. Vietnam Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 173. Vietnam Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 174. Vietnam Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 175. South Korea Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 176. South Korea Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 177. South Korea Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 178. South Korea Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 179. South Korea Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 180. South Korea Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 181. South Korea Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 182. Indonesia Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 183. Indonesia Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 184. Indonesia Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 185. Indonesia Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 186. Indonesia Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 187. Indonesia Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 188. Indonesia Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 189. Philippines Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 190. Philippines Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 191. Philippines Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 192. Philippines Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 193. Philippines Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 194. Philippines Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 195. Philippines Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 196. Middle East & Africa Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 197. Middle East & Africa Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 198. Middle East & Africa Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 199. Middle East & Africa Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 200. Middle East & Africa Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 201. Middle East & Africa Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 202. Middle East & Africa Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 203. Middle East & Africa Anti-Aging Market Share (%), By Country, 2017-2031F
• Figure 204. Saudi Arabia Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 205. Saudi Arabia Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 206. Saudi Arabia Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 207. Saudi Arabia Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 208. Saudi Arabia Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 209. Saudi Arabia Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 210. Saudi Arabia Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 211. UAE Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 212. UAE Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 213. UAE Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 214. UAE Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 215. UAE Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 216. UAE Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 217. UAE Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 218. South Africa Anti-Aging Market, By Value, In USD Billion, 2017-2031F
• Figure 219. South Africa Anti-Aging Market Share (%), By Product Category, 2017-2031F
• Figure 220. South Africa Anti-Aging Market Share (%), By Type, 2017-2031F
• Figure 221. South Africa Anti-Aging Market Share (%), By Ingredients, 2017-2031F
• Figure 222. South Africa Anti-Aging Market Share (%), By Demography, 2017-2031F
• Figure 223. South Africa Anti-Aging Market Share (%), By Route of Administration, 2017-2031F
• Figure 224. South Africa Anti-Aging Market Share (%), By Distribution Channel, 2017-2031F
• Figure 225. By Product Category Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 226. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 227. By Ingredients Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 228. By Demography Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 229. By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 230. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 231. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global anti-aging market is projected to witness a CAGR of 7.14% during the forecast period 2024-2031, growing from USD 80.03 billion in 2023 to USD 138.95 billion in 2031. The market for products used to manipulate the aging signs in the body is booming at a high pace owing to the rising consciousness about beauty standards and high disposable income of people coupled with medical advancements that enable the alteration of aging signs in the body.

Anti-aging products are cosmetic and treatment ranges that are marketed to combat the visible effects of aging, like wrinkles, fine lines, and skin discoloration. The products include serums, creams, masks, and supplements characterized by active ingredients, including retinol, hyaluronic acid, or antioxidants. Anti-aging products are in high demand for several reasons. The aging population worldwide is seeking a way to stay young-looking and heightened beauty awareness, and this impact is heightened due to social media leaving people more concerned with regimens towards their skin, therefore surmounting consumer spending on anti-aging products. Innovative ingredients and the development of new technology continue to fuel this trend since brands are still launching new products that prove to be effective. In addition, the growing tendency among consumers to adopt wellness and self-care practices has enabled skincare to be included in their health, which has contributed to rapid market growth in the anti-aging sector. For instance, in August 2024, Purple Pompa Beauty Culture Private Limited launched a new skincare line focused on anti-aging and skin rejuvenation. The innovative products incorporate advanced ingredients to promote youthful skin and enhance overall complexion. This launch reflects the brand's commitment to providing effective skincare solutions tailored to modern needs, targeting various skin concerns while ensuring quality and efficacy. The range is designed to cater to diverse skin types, appealing to a broad consumer base.

Growing Consciousness About Aging Signs to Boost Market Demand

Rising awareness about the manifestations of aging triggers a higher demand for anti-aging products. As a result of this fading look from wrinkles and fine lines and sagging skin, it has become quite easy for the young generation to apprehend that there is a real need to maintain a youthful appearance. Social media has intensified this awareness, further driven by social celebrities and advertisements set to make one's appearance young. The growing wellness and self-care focus promotes consumer spending on rejuvenation and revitalization products. Brands respond to the increased interest in the sector with new formulations featuring advanced ingredients like peptides and antioxidants. What matters here is the need to remove aging signs, fostering and interrelated societal requirements that ascribe value to younger age groups; consequently, sales increase with developments within the anti-aging category. For instance, according to a study published in Cureus Journal in October 2023, there is a significant shift in attitudes has been observed, with over 50% of United States women aged 18-24 considering the use of anti-aging regimes important and the number up from fewer than 20% in the year 2012.

Advancements in Ingredients and Novel Formulations Drive Market Growth

Innovative ingredients and innovative formulations fuel the growth in the anti-aging product market. Advances in dermatological research have led to the discovery of potent compounds like peptides, growth factors, and botanical extracts that address some specific signs of aging much more effectively than their predecessors. Also, these ingredients enhance the product's overall effectiveness, focusing on consumers looking for visible results. New formulations, such as encapsulated technologies and multi-functional products, improve absorption and targeted delivery, making them more appealing for anti-aging treatments. Innovation does not only boost consumer confidence in productivity with the product but also assures loyalty to the brand. This has further emphasized the necessity of natural and sustainable ingredients and increased appeal. As consumers become better informed and discerning, demand will grow for highly developed formulations that promise transformative results, an added driver of competition and investment in research and development within the anti-aging market.

For instance, in July 2024, SkinCeuticals (L'Oreal USA S/D, Inc.) launched P-TIOX, a clinically backed wrinkle-modulating peptide serum designed to reduce contraction lines and improve skin radiance. This innovative serum combines advanced peptides and synergistic actives, showing effectiveness in just one week and significant results in twelve weeks. P-TIOX is intended for all skin types and can complement neurotoxin injections or be used independently for needle-free wrinkle correction.

Anti-Wrinkle Products Segment is Growing the Fastest in Anti-Aging Market

The anti-wrinkle market segment is developing very rapidly because of the awareness of customers regarding age-related problems concerning skin and people belonging to an elderly population. Consumers' willingness to spend money for the youthfulness of their skin has increased, and thus, the demand for effective solutions like creams and serums is also high. Growth in this space is primarily driven by new product launches, in which brands continually push formulations forward with newer, high-tech ingredients and technologies. For example, new products with advanced delivery systems increase the ingredients' efficacy. This chimes well with the fact that consumer expectations are now high on tangible results, and brand loyalty will move the anti-wrinkle market forward. For instance, in August 2024, Neutrogena JNTL Consumer Health (India) Private Limited) launched Visible Repair range with innovative solutions for early signs of aging. The Neutrogena Visible Repair range consists of three products: a serum, a regenerating cream, and an under-eye cream. This range features fast-acting retinol along with other powerful anti-aging ingredients that boost collagen production by 48% while preserving the skin's natural collagen. As a result, it enhances skin elasticity and firmness.

Asia-Pacific is Dominates the Anti-Aging Market

In Asia-Pacific, due to dominant influences from social media and K-Pop, perfection reflects a flawless and youthful appearance. The beauty ideals in South Korea include smooth skin, a slender V-shaped jawline, and large eyes, which are more often pursued through cosmetic surgical procedures, including double eyelid surgery and whitening treatments for the skin. Consequently, the increased popularity of K-pop has resulted in higher demand for anti-aging products because most consumers want to look younger. Such trends are socially exaggerated and made more important, especially when it comes to beauty products such as improving skincare or combating conditions associated with aging. Therefore, the anti-aging market in this region is dramatically changing in favor of skincare solutions that meet these ideals of beauty. The shifting paradigm of market players towards the expansion of such products further boosts the market; for instance, in September 2023, South Korea's hy Co., Ltd., formerly Korea Yakult, launched cosmetics made with fermented products using its self-developed lactic acid bacteria, broadening the use of probiotics beyond just improving intestinal health. They released the cream-type Leti 7714 Triple Lift-up Anti-aging Cream, which is their second cosmetic product utilizing skin lactobacillus 7714, a fermented product derived from cultured lactic acid bacteria.

Future Market Scenario (2024-2031F)

Nanotechnology is changing the anti-aging industry as it maximizes the delivery and efficacy of active ingredients in skincare creams, gels, serums, masks, and liquid treatments. These formulations use nanoparticles to penetrate deeper into the skin, thus targeting specific cells that are causing aging while improving the stability and bioavailability of compounds, such as antioxidants and peptides, thereby maximizing rejuvenation effects. Additionally, nanotechnology makes it possible to use a controlled release mechanism. Hence, active ingredients may deliver longer action to reduce the formation of fine wrinkles and lines. Advancements in areas such as nanoemulsions and nanocapsules are currently being developed to preserve sensitive actives from further degradation and remain effective over time. With increasing waves of consumers demanding more efficient and scientifically backed treatments, nanotechnology can only rise to center stage shortly for anti-aging treatments.

Key Players Landscape and Outlook

The anti-aging market is quite a mix of consumer products, and the pharmaceutical industry is fostering a huge number of market players, including various pharmaceutical, cosmetics, and consumer product companies. The market is highly active, with rapid technical advancements and innovative product launches. Recent market activities include acquisitions and product launches coupled with several other business deals.

In August 2024, Revance Therapeutics Inc., known for its anti-wrinkle injections, is set to go private in a USD 924 million acquisition by Crown Laboratories, Inc. This deal, which includes debt, reflects a strategic move to enhance Revance's market presence in the skincare industry. The transition aims to leverage Crown's resources and expertise to further develop and expand Revance's innovative anti-aging products, potentially offering consumers more advanced wrinkle reduction and skin rejuvenation solutions.

In January 2024, Bridgepoint Group plc acquired the anti-aging cosmetics brand Roc Skincare (RoC Opco LLC) for approximately USD 500 million. Originally carved out from Johnson & Johnson in 2019, Roc Skincare offers a range of products, including retinol and eye creams, sold globally through various channels. This acquisition aligns with Bridgepoint's strategy of investing in beauty brands to expand its market presence.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Anti-Aging Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product Category
    • 4.2.1.1. Anti-Wrinkle Products
    • 4.2.1.2. Anti-Stretch Mark Products
    • 4.2.1.3. Hair Color Products
    • 4.2.1.4. Others
  • 4.2.2. By Type
    • 4.2.2.1. Creams
    • 4.2.2.2. Moisturizers
    • 4.2.2.3. Serums
    • 4.2.2.4. Gels
    • 4.2.2.5. Dermal Fillers
    • 4.2.2.6. Botulinum Toxin
    • 4.2.2.7. Chemical Peels
    • 4.2.2.8. Devices
      • 4.2.2.8.1. Radio-Frequency Devices
      • 4.2.2.8.2. Anti-Cellulite Treatment Devices
      • 4.2.2.8.3. Microdermabrasion Devices
      • 4.2.2.8.4. Other Devices
    • 4.2.2.9. Others
  • 4.2.3. By Ingredients
    • 4.2.3.1. Retinols
    • 4.2.3.2. Hyaluronic Acid
    • 4.2.3.3. Alpha Hydroxy Acid
    • 4.2.3.4. Others
  • 4.2.4. By Demography
    • 4.2.4.1. Age Group
      • 4.2.4.1.1. 18-27 Years
      • 4.2.4.1.2. 28-37 Years
      • 4.2.4.1.3. 37-46 Years
      • 4.2.4.1.4. 46-55 Years
      • 4.2.4.1.5. 55 and Above
    • 4.2.4.2. Gender
      • 4.2.4.2.1. Male
      • 4.2.4.2.2. Female
  • 4.2.5. By Route of Administration
    • 4.2.5.1. Oral
    • 4.2.5.2. Parenteral
    • 4.2.5.3. Topical
  • 4.2.6. By Distribution Channel
    • 4.2.6.1. Dermatology Clinics
    • 4.2.6.2. Hospitals
    • 4.2.6.3. Pharmacies
    • 4.2.6.4. Rejuvenation Centers
    • 4.2.6.5. Others
  • 4.2.7. By Region
    • 4.2.7.1. North America
    • 4.2.7.2. Europe
    • 4.2.7.3. Asia-Pacific
    • 4.2.7.4. South America
    • 4.2.7.5. Middle East and Africa
  • 4.2.8. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Product Category
  • 4.3.2. By Type
  • 4.3.3. By Ingredients
  • 4.3.4. By Demographics
  • 4.3.5. By Route of Administration
  • 4.3.6. By Distribution Channel
  • 4.3.7. By Region

5. North America Anti-Aging Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product Category
    • 5.2.1.1. Anti-wrinkle Products
    • 5.2.1.2. Anti-stretch Mark Products
    • 5.2.1.3. Hair Color Products
    • 5.2.1.4. Other Products
  • 5.2.2. By Type
    • 5.2.2.1. Creams
    • 5.2.2.2. Moisturizers
    • 5.2.2.3. Serums
    • 5.2.2.4. Gels
    • 5.2.2.5. Dermal Fillers
    • 5.2.2.6. Botulinum Toxin
    • 5.2.2.7. Chemical Peels
    • 5.2.2.8. Devices
      • 5.2.2.8.1. Radio-frequency Devices
      • 5.2.2.8.2. Anti-cellulite Treatment Devices
      • 5.2.2.8.3. Microdermabrasion Devices
      • 5.2.2.8.4. Other Devices
    • 5.2.2.9. Others
  • 5.2.3. By Ingredients
    • 5.2.3.1. Retinols
    • 5.2.3.2. Hyaluronic Acid
    • 5.2.3.3. Alpha Hydroxy Acid
    • 5.2.3.4. Others
  • 5.2.4. By Demography
    • 5.2.4.1. Age Group
      • 5.2.4.1.1. 18-27 Years
      • 5.2.4.1.2. 28-37 Years
      • 5.2.4.1.3. 37-46 Years
      • 5.2.4.1.4. 46-55 Years
      • 5.2.4.1.5. 55 and above
    • 5.2.4.2. Gender
      • 5.2.4.2.1. Male
      • 5.2.4.2.2. Female
  • 5.2.5. By Route of Administration
    • 5.2.5.1. Oral
    • 5.2.5.2. Parenteral
    • 5.2.5.3. Topical
  • 5.2.6. By Distribution Channel
    • 5.2.6.1. Dermatology Clinics
    • 5.2.6.2. Hospitals
    • 5.2.6.3. Pharmacies
    • 5.2.6.4. Rejuvenation Centers
    • 5.2.6.5. Others
  • 5.2.7. By Country Share
    • 5.2.7.1. United States
    • 5.2.7.2. Canada
    • 5.2.7.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Anti-Aging Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Product Category
        • 5.3.1.2.1.1. Anti-wrinkle Products
        • 5.3.1.2.1.2. Anti-stretch Mark Products
        • 5.3.1.2.1.3. Hair Color Products
        • 5.3.1.2.1.4. Other Products
      • 5.3.1.2.2. By Type
        • 5.3.1.2.2.1. Creams
        • 5.3.1.2.2.2. Moisturizers
        • 5.3.1.2.2.3. Serums
        • 5.3.1.2.2.4. Gels
        • 5.3.1.2.2.5. Dermal Fillers
        • 5.3.1.2.2.6. Botulinum Toxin
        • 5.3.1.2.2.7. Chemical Peels
        • 5.3.1.2.2.8. Devices
        • 5.3.1.2.2.8.1. Radio-frequency Devices
        • 5.3.1.2.2.8.2. Anti-cellulite Treatment Devices
        • 5.3.1.2.2.8.3. Microdermabrasion Devices
        • 5.3.1.2.2.8.4. Other Devices
        • 5.3.1.2.2.9. Others
      • 5.3.1.2.3. By Ingredients
        • 5.3.1.2.3.1. Retinols
        • 5.3.1.2.3.2. Hyaluronic Acid
        • 5.3.1.2.3.3. Alpha Hydroxy Acid
        • 5.3.1.2.3.4. Others
      • 5.3.1.2.4. By Demography
        • 5.3.1.2.4.1. Age Group
        • 5.3.1.2.4.1.1. 18-27 Years
        • 5.3.1.2.4.1.2. 28-37 Years
        • 5.3.1.2.4.1.3. 37-46 Years
        • 5.3.1.2.4.1.4. 46-55 Years
        • 5.3.1.2.4.1.5. 55 and above
        • 5.3.1.2.4.2. Gender
        • 5.3.1.2.4.2.1. Male
        • 5.3.1.2.4.2.2. Female
      • 5.3.1.2.5. By Route of Administration
        • 5.3.1.2.5.1. Oral
        • 5.3.1.2.5.2. Parenteral
        • 5.3.1.2.5.3. Topical
      • 5.3.1.2.6. By Distribution Channel
        • 5.3.1.2.6.1. Dermatology Clinics
        • 5.3.1.2.6.2. Hospitals
        • 5.3.1.2.6.3. Pharmacies
        • 5.3.1.2.6.4. Rejuvenation Centers
        • 5.3.1.2.6.5. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Anti-Aging Market Outlook, 2017-2031F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Anti-Aging Market Outlook, 2017-2031F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Anti-Aging Market Outlook, 2017-2031F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Anti-Aging Market Outlook, 2017-2031F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

• 15.1. Market Drivers
• 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

• 17.1. Clinical Trials
• 17.2. Regulatory Approvals

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

• 20.1. Competition Matrix of Top 5 Market Leaders
• 20.2. SWOT Analysis for Top 5 Players
• 20.3. Key Players Landscape for Top 10 Market Players
  • 20.3.1. Allergan Inc.
    • 20.3.1.1. Company Details
    • 20.3.1.2. Key Management Personnel
    • 20.3.1.3. Products and Services
    • 20.3.1.4. Financials (As Reported)
    • 20.3.1.5. Key Market Focus and Geographical Presence
    • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 20.3.2. Beiersdorf AG
  • 20.3.3. Procter & Gamble Co.
  • 20.3.4. Unilever plc
  • 20.3.5. Cynosure Inc.
  • 20.3.6. Shiseido Company Limited
  • 20.3.7. Age Sciences Inc.
  • 20.3.8. Lumenis Ltd.
  • 20.3.9. Solta Medical Inc.
  • 20.3.10. Nestle S.A.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer